The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm ...

Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...

Two Israeli stocks have been included in the top picks 2025 lists of US analysts. Bank of America chose Teva Pharmaceutical ...

Cantor Fitzgerald analyst Deepak Mathivanan downgraded Sabre (SABR) to Neutral from Overweight with a price target of $4, down from $5, after ...

Cantor Fitzgerald raised the firm’s price target on Shopify (SHOP) to $120 from $110 and keeps a Neutral rating on the shares as part of a ...

Cantor Fitzgerald began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a report issued on Tuesday morning, Marketbeat Ratings reports. The firm issued an overweight ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares are ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.56% of ...

TD Cowen assumed coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a research report released ...

Esperion Therapeutics Inc (ESPR) stock saw a modest uptick, ending the day at $2.17 which represents a slight increase of $0.02 or 0.93% from the prior close of $2.15. The stock opened at $2.15 and ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...